These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
657 related articles for article (PubMed ID: 19476560)
1. Prevalence and risk factors for non-alcoholic fatty liver disease among adults in an urban Sri Lankan population. Dassanayake AS; Kasturiratne A; Rajindrajith S; Kalubowila U; Chakrawarthi S; De Silva AP; Makaya M; Mizoue T; Kato N; Wickremasinghe AR; de Silva HJ J Gastroenterol Hepatol; 2009 Jul; 24(7):1284-8. PubMed ID: 19476560 [TBL] [Abstract][Full Text] [Related]
2. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific? Fan JG; Saibara T; Chitturi S; Kim BI; Sung JJ; Chutaputti A; J Gastroenterol Hepatol; 2007 Jun; 22(6):794-800. PubMed ID: 17498218 [TBL] [Abstract][Full Text] [Related]
3. Prevalence and etiology of elevated serum alanine aminotransferase level in an adult population in Taiwan. Chen CH; Huang MH; Yang JC; Nien CK; Yang CC; Yeh YH; Yueh SK J Gastroenterol Hepatol; 2007 Sep; 22(9):1482-9. PubMed ID: 17716352 [TBL] [Abstract][Full Text] [Related]
4. Prevalence of primary non-alcoholic fatty liver disease in a population-based study and its association with biochemical and anthropometric measures. Zelber-Sagi S; Nitzan-Kaluski D; Halpern Z; Oren R Liver Int; 2006 Sep; 26(7):856-63. PubMed ID: 16911469 [TBL] [Abstract][Full Text] [Related]
5. Non-alcoholic fatty liver disease--a common and benign finding in octogenarian patients. Kagansky N; Levy S; Keter D; Rimon E; Taiba Z; Fridman Z; Berger D; Knobler H; Malnick S Liver Int; 2004 Dec; 24(6):588-94. PubMed ID: 15566509 [TBL] [Abstract][Full Text] [Related]
6. Significant correlations between severe fatty liver and risk factors for metabolic syndrome. Hsiao PJ; Kuo KK; Shin SJ; Yang YH; Lin WY; Yang JF; Chiu CC; Chuang WL; Tsai TR; Yu ML J Gastroenterol Hepatol; 2007 Dec; 22(12):2118-23. PubMed ID: 18031368 [TBL] [Abstract][Full Text] [Related]
7. Relationships between estimates of adiposity, insulin resistance, and nonalcoholic fatty liver disease in a large group of nondiabetic Korean adults. Sung KC; Ryan MC; Kim BS; Cho YK; Kim BI; Reaven GM Diabetes Care; 2007 Aug; 30(8):2113-8. PubMed ID: 17475935 [TBL] [Abstract][Full Text] [Related]
8. Prevalence of non-alcoholic fatty liver disease in urban south Indians in relation to different grades of glucose intolerance and metabolic syndrome. Mohan V; Farooq S; Deepa M; Ravikumar R; Pitchumoni CS Diabetes Res Clin Pract; 2009 Apr; 84(1):84-91. PubMed ID: 19168251 [TBL] [Abstract][Full Text] [Related]
9. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Bedogni G; Miglioli L; Masutti F; Tiribelli C; Marchesini G; Bellentani S Hepatology; 2005 Jul; 42(1):44-52. PubMed ID: 15895401 [TBL] [Abstract][Full Text] [Related]
10. Frequency and predictors of nonalcoholic fatty liver disease in myotonic dystrophy. Shieh K; Gilchrist JM; Promrat K Muscle Nerve; 2010 Feb; 41(2):197-201. PubMed ID: 19813185 [TBL] [Abstract][Full Text] [Related]
11. [Epidemiological survey of prevalence of fatty liver and its risk factors in a general adult population of Shanghai]. Fang JG; Zhu J; Li XJ; Li R; Dai F; Song XM; Chen L; Li F; Chen SY Zhonghua Gan Zang Bing Za Zhi; 2005 Feb; 13(2):83-8. PubMed ID: 15727689 [TBL] [Abstract][Full Text] [Related]
12. Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors. Guaraldi G; Squillace N; Stentarelli C; Orlando G; D'Amico R; Ligabue G; Fiocchi F; Zona S; Loria P; Esposito R; Palella F Clin Infect Dis; 2008 Jul; 47(2):250-7. PubMed ID: 18532884 [TBL] [Abstract][Full Text] [Related]
13. Non-alcoholic fatty liver disease and its associations among adolescents in an urban, Sri Lankan community. Rajindrajith S; Pathmeswaran A; Jayasinghe C; Kottahachchi D; Kasturiratne A; de Silva ST; Niriella MA; Dassanayake AS; de Silva AP; de Silva HJ BMC Gastroenterol; 2017 Nov; 17(1):135. PubMed ID: 29187144 [TBL] [Abstract][Full Text] [Related]
14. NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study. Adams LA; Waters OR; Knuiman MW; Elliott RR; Olynyk JK Am J Gastroenterol; 2009 Apr; 104(4):861-7. PubMed ID: 19293782 [TBL] [Abstract][Full Text] [Related]
15. The epidemiology of nonalcoholic fatty liver disease in adults. Clark JM J Clin Gastroenterol; 2006 Mar; 40 Suppl 1():S5-10. PubMed ID: 16540768 [TBL] [Abstract][Full Text] [Related]
18. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia. Gündogan K; Bayram F; Capak M; Tanriverdi F; Karaman A; Ozturk A; Altunbas H; Gökce C; Kalkan A; Yazici C Metab Syndr Relat Disord; 2009 Oct; 7(5):427-34. PubMed ID: 19754305 [TBL] [Abstract][Full Text] [Related]
19. Nonalcoholic fatty liver disease is associated with blood pressure in hypertensive and nonhypertensive individuals from the general population with normal levels of alanine aminotransferase. López-Suárez A; Guerrero JM; Elvira-González J; Beltrán-Robles M; Cañas-Hormigo F; Bascuñana-Quirell A Eur J Gastroenterol Hepatol; 2011 Nov; 23(11):1011-7. PubMed ID: 21915061 [TBL] [Abstract][Full Text] [Related]
20. Prevalence and factors associated with the presence of nonalcoholic fatty liver disease in an adult population in Spain. Caballería L; Pera G; Auladell MA; Torán P; Muñoz L; Miranda D; Alumà A; Casas JD; Sánchez C; Gil D; Aubà J; Tibau A; Canut S; Bernad J; Aizpurua MM Eur J Gastroenterol Hepatol; 2010 Jan; 22(1):24-32. PubMed ID: 19730384 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]